[Polymer ocular implants with controlled release of drugs. II. Preliminary testing of implants with incorporated pilocarpine].
Czechowicz-Janicka
K
K
Kliniki Okulistycznej CMKP, Warszawie.
Romaniuk
I
I
Piekarniak
A
A
Galant
S
S
Kamińska
E
E
Rosiak
J
J
D000818:Animals; D001672:Biocompatible Materials; D003228:Conjunctiva / Q000187:drug effects*; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005260:Female; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007498:Iris / Q000187:drug effects*; D008297:Male; D008954:Models, Biological; D010862:Pilocarpine / Q000008:administration & dosage*; D011092:Polyethylene Glycols; D011817:Rabbits
D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004343:Drug Implants; D010862:Pilocarpine; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D011092:Polyethylene Glycols
Polimerowe wkładki do oka z kontrolowanym uwalnianiem leku. II. Wstepne badania wkładek inkorporowanych pilokarpina.